Related Experiment Video
Updated: Feb 8, 2026

An R-Based Landscape Validation of a Competing Risk Model
Published on: September 16, 2022
Risk stratification based on J-ACCESS risk models with myocardial perfusion imaging: Risk versus outcomes of patients
Kenichi Nakajima1, Satoko Nakamura2,3, Hiroki Hase4
1Department of Nuclear Medicine, Kanazawa University Hospital, Kanazawa, 920-8641, Japan.
Insights
The J-ACCESS risk models accurately stratify major cardiac events in chronic kidney disease (CKD) patients with estimated glomerular filtration rate (eGFR) ≥15. However, patients with eGFR <15 require careful risk assessment due to consistently high event rates.
Area of Science:
- Nephrology
- Cardiology
- Prognostic Modeling
Background:
- Chronic kidney disease (CKD) poses significant cardiovascular risks.
- Accurate prediction of major cardiac events is crucial for managing CKD patients.
- Existing prognostic models require validation in diverse CKD cohorts.
Purpose of the Study:
- To validate the J-ACCESS risk models for major cardiac events in a new cohort of CKD patients.
- To assess the models' accuracy across different levels of kidney function.
- To determine the models' utility in guiding clinical risk stratification.
Main Methods:
- Validation of three multivariable J-ACCESS risk models (using age, stress score, ejection fraction, diabetes, and eGFR) in a 526-patient CKD cohort.
- Analysis of three-year major cardiac event rates (cardiac death, acute coronary syndrome, severe heart failure).
- Stratification of patients into low, intermediate, and high-risk groups based on model predictions and actual event rates.
Main Results:
- All three J-ACCESS models demonstrated good risk stratification for CKD patients with estimated glomerular filtration rate (eGFR) ≥15 mL/min/1.73 m².
- Patients with eGFR ≥15 showed distinct event rates across low (3.1%), intermediate (9.9%), and high (15.9%) risk groups (Model 2).
- CKD patients with eGFR <15 mL/min/1.73 m² exhibited similarly high event rates across all risk strata, irrespective of model-predicted risk.
Conclusions:
- The J-ACCESS risk models are effective for stratifying cardiovascular risk in CKD patients with eGFR ≥15.
- Patients with severe CKD (eGFR <15) may be at high risk for major cardiac events, necessitating vigilant monitoring.
- Further research is needed to refine risk prediction models for the most severe CKD population.
Background:
This study aimed to validate the accuracy of major-event risk models created in the multicenter J-ACCESS prognostic study in a new cohort of patients with chronic kidney disease (CKD).
Methods And Results:
Three multivariable J-ACCESS risk models were created to predict major cardiac events (cardiac death, non-fatal acute coronary syndrome, and severe heart failure requiring hospitalization): Model 1, four variables of age, summed stress score, left ventricular ejection fraction and diabetes; Model 2 with five variables including estimated glomerular filtration rate (eGFR, continuous); and Model 3 with categorical eGFR. The validation data used three-year (3y) cohort of patients with CKD (n = 526, major events 11.2%). Survival analysis of low (< 3%/3y), intermediate (3% to 9%/3y), and high (> 9%/3y)-risk groups showed good stratification by all three models (actual event rates: 3.1%, 9.9%, and 15.9% in the three groups with eGFR ≥ 15 mL/min/1.73 m2, P = .0087 (Model 2). However, actual event rates were equally high across all risk groups of patients with eGFR < 15 mL/min/1.73 m2.
Conclusion:
The J-ACCESS risk models can stratify patients with CKD and eGFR ≥ 15 mL/min/1.73 m2, but patients with eGFR < 15 mL/min/1.73 m2 are potentially at high risk regardless of estimated risk values.
Related Concept Videos
Relative Risk
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Design Example: Analyzing Capacity Contours for Flood Risk Assessment
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease III: Interprofessional Care

